Literature DB >> 12091476

Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity.

Henrik H Hansen1, Iñigo Azcoitia, Sebastián Pons, Julián Romero, Luis Miguel García-Segura, José Antonio Ramos, Harald S Hansen, Javier Fernández-Ruiz.   

Abstract

The ability of cannabinoid CB(1) receptors to influence glutamatergic excitatory neurotransmission has fueled interest in how these receptors and their endogenous ligands may interact in conditions of excitotoxic insults. The present study characterized the impact of stimulated and inhibited CB(1) receptor function on NMDA-induced excitotoxicity. Neonatal (6-day-old) rat pups received a systemic injection of a mixed CB(1) /CB(2) receptor agonist (WIN55,212-2) or their respective antagonists (SR141716A for CB(1) and SR144528 for CB(2) ) prior to an unilateral intrastriatal microinjection of NMDA. The NMDA-induced excitotoxic damage in the ipsilateral forebrain was not influenced by agonist-stimulated CB(1) receptor function. In contrast, blockade of CB(1), but not CB(2), receptor activity evoked a robust neuroprotective response by reducing the infarct area and the number of cortical degenerating neurons. These results suggest a critical involvement of CB(1) receptor tonus on neuronal survival following NMDA receptor-induced excitotoxicity in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091476     DOI: 10.1046/j.1471-4159.2002.00961.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

Review 1.  Cannabinoids and neuroprotection in basal ganglia disorders.

Authors:  Onintza Sagredo; Moisés García-Arencibia; Eva de Lago; Simone Finetti; Alessandra Decio; Javier Fernández-Ruiz
Journal:  Mol Neurobiol       Date:  2007-06-23       Impact factor: 5.590

2.  Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage.

Authors:  Basma Shouman; Romain H Fontaine; Olivier Baud; Leslie Schwendimann; Matthias Keller; Michael Spedding; Vincent Lelièvre; Pierre Gressens
Journal:  Br J Pharmacol       Date:  2006-05-08       Impact factor: 8.739

3.  Effect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats.

Authors:  T Croci; E Zarini
Journal:  Br J Pharmacol       Date:  2007-01-22       Impact factor: 8.739

4.  Protective effects of Delta(9)-tetrahydrocannabinol against N-methyl-d-aspartate-induced AF5 cell death.

Authors:  Jia Chen; Chun-Ting Lee; Stacie Errico; Xiaolin Deng; Jean L Cadet; William J Freed
Journal:  Brain Res Mol Brain Res       Date:  2005-04-04

Review 5.  Cannabinoid receptors and their role in neuroprotection.

Authors:  Mario van der Stelt; Vincenzo Di Marzo
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 6.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.

Authors:  Mario van der Stelt; Henrik H Hansen; Wouter B Veldhuis; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Johannes F G Vliegenthart; Harald S Hansen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

7.  Brain levels of N-acylethanolamine phospholipids in mice during pentylenetetrazol-induced seizure.

Authors:  Birthe Moesgaard; Henrik H Hansen; Suzanne L Hansen; Steen Honore Hansen; Gitte Petersen; Harald S Hansen
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

Review 8.  Role of cannabinoids and endocannabinoids in cerebral ischemia.

Authors:  Cecilia J Hillard
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

9.  Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice.

Authors:  K Yaragudri Vinod; Ratnakumar Yalamanchili; Panayotis K Thanos; Csaba Vadasz; Thomas B Cooper; Nora D Volkow; Basalingappa L Hungund
Journal:  Synapse       Date:  2008-08       Impact factor: 2.562

Review 10.  Neuropathological and biochemical features of traumatic injury in the developing brain.

Authors:  Petra Bittigau; Marco Sifringer; Ursula Felderhoff-Mueser; Henrik H Hansen; Chrysanthy Ikonomidou
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.